James Sapirstein's Insider Trades & SAST Disclosures
James Sapirstein's most recent trade in Onconetix Inc was a trade of 3,318 Common Stock done . Disclosure was reported to the exchange on Sept. 26, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James Sapirstein.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Onconetix Inc | James Sapirstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Sep 2024 | 3,318 | 3,477 | - | 0 | Common Stock | |
| Entero Therapeutics Inc. | James Sapirstein | Director, Chairman and CEO | 02 Jul 2024 | 1,289 | 35,816 (0%) | 0% | 1.1 | 1,379 | Common Stock | |
| Renovaro Biosciences Inc | James Sapirstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 48,137 | 48,137 | - | - | Option to purchase shares of common stock | |
| First Wave BioPharma Inc | James Sapirstein | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 4.23 per share. | 01 Apr 2024 | 174 | 37,105 (0%) | 0% | 4.2 | 736 | Common Stock |
| First Wave BioPharma Inc | James Sapirstein | Director, Chairman and CEO | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 15 Mar 2024 | 1,887 | 37,279 (0%) | 0% | 5.0 | 9,360 | Common Stock |
| Renovaro Biosciences Inc | James Sapirstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2024 | 28,196 | 28,196 | - | - | Option to Purchase Common Stock | |
| First Wave BioPharma Inc | Sapirstein James | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 4.20 per share. | 12 Jan 2024 | 166 | 39,166 (0%) | 0% | 4.2 | 697 | Common Stock |
| First Wave BioPharma Inc | Sapirstein James | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 20,000 | 39,332 (0%) | 0% | 0 | Common Stock | |
| First Wave BioPharma Inc | Sapirstein James | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 17,660 | 19,332 (0%) | 0% | 0 | Common Stock | |
| First Wave BioPharma Inc | James Sapirstein | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.54 per share. | 03 Jul 2023 | 3,349 | 36,161 (0%) | 0% | 1.5 | 5,157 | Common Stock |
| Blue Water Biotech Inc | James Sapirstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 6,360 | 6,360 | - | 0 | Common Stock | |
| ZyVersa Therapeutics Inc | Sapirstein James | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 132 | 132 | - | - | Stock Options | |
| First Wave BioPharma Inc | James Sapirstein | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.50 per share. | 03 Apr 2023 | 3,347 | 39,510 (0%) | 0% | 2.5 | 8,368 | Common Stock |
| Renovaro Biosciences Inc | James Sapirstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 64,655 | 64,655 | - | - | Option to Purchase Common Stock | |
| First Wave BioPharma Inc | James Sapirstein | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 300,000 | 300,000 (1%) | 1% | 0 | Common Stock | |
| Blue Water Biotech Inc | James Sapirstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2022 | 50,575 | 50,575 | - | - | Stock Option | |
| First Wave BioPharma Inc | James Sapirstein | Director, PRES, CEO & CHAIRMAN OF BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 150,000 | 150,000 | - | - | Stock option (right to buy) | |
| First Wave BioPharma Inc | James Sapirstein | Director, PRES, CEO & CHAIRMAN OF BOARD | Other type of transaction at price $ 0.00 per share. | 30 Jun 2021 | 900,000 | 300,000 | - | - | Stock options (right to buy) | |
| First Wave BioPharma Inc | James Sapirstein | Director, PRES, CEO & CHAIRMAN OF BOARD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 900,000 | 900,000 | - | - | Stock options (right to buy) | |
| Renovaro Biosciences Inc | James Sapirstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2021 | 19,894 | 19,894 | - | - | Option to Purchase Common Stock | |
| First Wave BioPharma Inc | James Sapirstein | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 1,200,000 | 1,200,000 | - | - | Stock options (right to buy) | |
| First Wave BioPharma Inc | James Sapirstein | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 64,935 | 64,935 | - | - | Series B Warrants | |
| First Wave BioPharma Inc | James Sapirstein | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2020 | 12 | 12 | - | - | Series B Convertible Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges